74936-93-9

Basic information

• Product Name: 2-Pyrrolidinecarbonyl chloride, 5-oxo-, (2S)- (9CI)
• Synonyms: 2-Pyrrolidinecarbonyl chloride, 5-oxo-, (2S)- (9CI)
• CAS NO: 74936-93-9
• Molecular Formula: C₅H₆ClNO₂
• Molecular Weight: 147.55964
• Product Categories: ACIDHALIDE
• Mol File: 74936-93-9.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 329.0±35.0 °C(Predicted)
• Appearance: /
• Density: 1.374±0.06 g/cm3(Predicted)
• PKA: 14.33±0.40(Predicted)
• CAS DataBase Reference: 2-Pyrrolidinecarbonyl chloride, 5-oxo-, (2S)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidinecarbonyl chloride, 5-oxo-, (2S)- (9CI)(74936-93-9)
• EPA Substance Registry System: 2-Pyrrolidinecarbonyl chloride, 5-oxo-, (2S)- (9CI)(74936-93-9)

Safety Data

• Hazardous Substances Data: 74936-93-9(Hazardous Substances Data)

Upstream product

• 97717-45-8 L-trimethylsilyl pyroglutamate 
• 98-79-3 L-Pyroglutamic acid 
• 56-86-0 L-glutamic acid 

Downstream Products

• 135958-20-2 p-t-butylphenyl (S)-5-oxo-2-pyrrolidinylcarboxylate 
• 135958-21-3 bis<2-((S)-5-oxo-2-pyrrolidinylcarbonyloxy)-5-t-butylphenyl>methane 
• 7149-65-7 ethyl (S)-pyroglutamate 
• 14390-32-0 3,5-8,10-tetraketo-perhydropyrrolo 
• 35418-16-7 L-t-butyl pyroglutamate 
• 108963-96-8 (S)-1-tert-butoxycarbonyl-5-methoxycarbonyl-pyrrolidin-2-one 
• 1620014-32-5 N-{4-[(3S,5R)-3-amino-5-methylpiperidin-1-yl]-2,3-dihydrofuro[2,3-b]pyridin-5-yl}-6-(2,6-difluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxamide 
• 1620014-15-4 N-{4-[(3S,5R)-3-amino-5-methylpiperidin-1-yl]-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl}-6-[2,6-difluoro-4-(tetrahydro-2H-pyran-3-yloxy)phenyl]-5-fluoropyridine-2-carboxamide 
• 1620014-19-8 tert-butyl ((3S,5R)-1-{3-[({6-[2,6-difluoro-4-(tetrahydro-2H-pyran-3-yloxy)phenyl]-5-fluoropyridin-2-yl}carbonyl)amino]-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl}-5-methylpiperidin-3-yl)carbamate 
• 1620014-17-6 4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}-3-[({6-[2,6-difluoro-4-(tetrahydro-2H-pyran-3-yloxy)phenyl]-5-fluoropyridin-2-yl}carbonyl)amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate 
• 1620013-73-1 N-{4-[(3S,5R)-3-amino-5-methylpiperidin-1-yl]-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl}-6-[2,6-difluoro-4-(methoxymethyl)phenyl]-5-fluoropyridine-2-carboxamide 
• 1620013-75-3 4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}-3-[({6-[2,6-difluoro-4-(methoxymethyl)phenyl]-5-fluoropyridin-2-yl}carbonyl)amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate 
• 1620013-35-5 4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}-3-[({6-[2,6-difluoro-4-(methylsulfinyl)phenyl]-5-fluoropyridin-2-yl}carbonyl)amino]-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate 
• 1620013-17-3 4-{(3S,5R)-3-[(tert-butoxycarbonyl)amino]-5-methylpiperidin-1-yl}-3-({[6-(2,6-difluoro-3-methoxyphenyl)-5-fluoropyridin-2-yl]carbonyl}amino)-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl acetate 

Relevant articles and documents

SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF

The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

Identification of indole inhibitors of human hematopoietic prostaglandin D2 synthase (hH-PGDS)

Abstract Human H-PGDS has shown promise as a potential target for anti-allergic and anti-inflammatory drugs. Here we describe the discovery of a novel class of indole inhibitors, identified through focused screening of 42,000 compounds and evaluated using a series of hit validation assays that included fluorescence polarization binding, 1D NMR, ITC and chromogenic enzymatic assays. Compounds with low nanomolar potency, favorable physico-chemical properties and inhibitory activity in human mast cells have been identified. In addition, our studies suggest that the active site of hH-PGDS can accommodate larger structural diversity than previously thought, such as the introduction of polar groups in the inner part of the binding pocket.

Synthesis and biological evaluation of 7-substituted-1-(3-bromophenylamino) isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase and epidermal growth factor receptor

Here we present the synthesis and biological activity of a series of 7-substituted-1-(3-bromophenylamino)isoquinoline-4-carbonitriles as inhibitors of myosin light chain kinase (MLCK) and the epidermal growth factor receptor kinase (EGFR). The inhibitory